This compound was also shown to be effective in improving the symptoms associated with AD, as well as reducing the serum IgE levels and the production of IL-4, IL-5 and IL-13 in skin lesions in a murine model of AD.106. This evidence concerns the gene IL13 and Alzheimer disease.